Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 5.84%3.21M | -68.28%2.09M | -18.73%3.03M | -18.35%6.59M | -9.93%3.73M | -27.55%8.08M | -37.61%4.14M | -26.62%11.15M | -7.27%6.63M | 4.18%15.19M |
| Operating income | 5.84%3.21M | -68.28%2.09M | -18.73%3.03M | -18.35%6.59M | -9.93%3.73M | -27.55%8.08M | -37.61%4.14M | -26.62%11.15M | -7.27%6.63M | 4.18%15.19M |
| Cost of sales | -1.36%-2.76M | 66.92%-1.9M | 18.67%-2.72M | 20.29%-5.75M | 9.95%-3.35M | 28.48%-7.22M | 36.90%-3.72M | 26.79%-10.09M | 7.77%-5.89M | -6.36%-13.78M |
| Operating expenses | -1.36%-2.76M | 66.92%-1.9M | 18.67%-2.72M | 20.29%-5.75M | 9.95%-3.35M | 28.48%-7.22M | 36.90%-3.72M | 26.79%-10.09M | 7.77%-5.89M | -6.36%-13.78M |
| Gross profit | 45.60%447K | -77.62%188K | -19.21%307K | -2.10%840K | -9.74%380K | -18.60%858K | -43.18%421K | -24.98%1.05M | -3.14%741K | -13.27%1.41M |
| Selling expenses | ---- | ---- | ---- | ---- | ---- | ---- | 52.44%-39K | ---- | 32.79%-82K | ---- |
| Administrative expenses | -85.34%-12.39M | 12.11%-11.35M | -6.26%-6.68M | 24.14%-12.92M | 4.60%-6.29M | 1.23%-17.03M | 25.56%-6.59M | -1.97%-17.24M | -14.39%-8.86M | 25.32%-16.91M |
| Research and development expenses | -472.92%-4.06M | -47.01%-2.09M | -133.99%-709K | 70.13%-1.42M | 79.77%-303K | 42.30%-4.76M | 77.02%-1.5M | -35.36%-8.25M | ---6.52M | 46.26%-6.09M |
| Impairment and provision | ---- | ---296.98M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of intangible assets | ---- | ---296.98M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | ---- | -100.00%-8K | -32.09%224.29M | 144,137.55%330.3M | 767,962.79%330.27M | -99.91%229K | -99.98%43K | 52,814.98%250.82M | 113,318.10%250.65M | 100.96%474K |
| Operating profit | -107.37%-16M | -197.93%-310.25M | -32.97%217.21M | 1,630.31%316.8M | 4,327.72%324.06M | -109.14%-20.7M | -103.25%-7.67M | 1,171.73%226.38M | 3,530.33%235.94M | 74.16%-21.12M |
| Financing cost | 11.13%-103.3M | -19.26%-260.1M | 11.59%-116.24M | 6.78%-218.1M | -18.87%-131.48M | -23.17%-233.97M | 3.68%-110.61M | 0.57%-189.95M | -31.49%-114.83M | -29.92%-191.03M |
| Earning before tax | -218.16%-119.3M | -677.82%-570.35M | -47.57%100.97M | 138.76%98.71M | 262.83%192.58M | -799.05%-254.67M | -197.66%-118.27M | 117.17%36.43M | 228.56%121.11M | 4.63%-212.16M |
| After-tax profit from continuing operations | -218.16%-119.3M | -677.82%-570.35M | -47.57%100.97M | 138.76%98.71M | 262.83%192.58M | -799.05%-254.67M | -197.66%-118.27M | 117.17%36.43M | 228.56%121.11M | 4.63%-212.16M |
| Earning after tax | -218.16%-119.3M | -677.82%-570.35M | -47.57%100.97M | 138.76%98.71M | 262.83%192.58M | -799.05%-254.67M | -197.66%-118.27M | 117.17%36.43M | 228.56%121.11M | 4.63%-212.16M |
| Minority profit | -303.61%-3.13M | -4,678.73%-224.41M | 30.24%-775K | 47.67%-4.7M | 57.45%-1.11M | 4.26%-8.97M | 34.15%-2.61M | -29.88%-9.37M | -423.09%-3.97M | 36.39%-7.22M |
| Profit attributable to shareholders | -214.19%-116.18M | -434.55%-345.94M | -47.47%101.74M | 142.09%103.4M | 267.46%193.69M | -636.42%-245.7M | -192.47%-115.66M | 122.35%45.8M | 233.84%125.08M | 2.93%-204.94M |
| Basic earnings per share | -201.70%-0.0597 | -395.57%-0.2001 | -55.63%0.0587 | 140.35%0.0677 | 267.47%0.1323 | -636.10%-0.1678 | -192.51%-0.079 | 122.36%0.0313 | 233.86%0.0854 | 2.91%-0.14 |
| Diluted earnings per share | -2,885.00%-0.0597 | -2,340.24%-0.2001 | 91.74%-0.002 | 95.11%-0.0082 | 69.37%-0.0242 | -367.41%-0.1678 | -192.51%-0.079 | 74.36%-0.0359 | 233.86%0.0854 | 2.91%-0.14 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unaudited opinion | -- | -- |
| Auditor | -- | -- | -- | Kaiyuan Xinde Certified Public Accountants Co., Ltd. | -- | Kaiyuan Xinde Certified Public Accountants Co., Ltd. | -- | Kaiyuan Xinde Certified Public Accountants Co., Ltd. | -- | Kaiyuan Xinde Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.